PMID- 31441247
OWN - NLM
STAT- MEDLINE
DCOM- 20200527
LR  - 20200527
IS  - 2233-6079 (Print)
IS  - 2233-6087 (Electronic)
IS  - 2233-6079 (Linking)
VI  - 43
IP  - 4
DP  - 2019 Aug
TI  - 2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea.
PG  - 398-406
LID - 10.4093/dmj.2019.0137 [doi]
AB  - The Committee of Clinical Practice Guidelines of the Korean Diabetes Association 
      revised and updated the 6th Clinical Practice Guidelines in 2019. Targets of 
      glycemic, blood pressure, and lipid control in type 2 diabetes mellitus (T2DM) 
      were updated. The obese and overweight population is increasing steadily in 
      Korea, and half of the Koreans with diabetes are obese. Evidence-based 
      recommendations for weight-loss therapy for obesity management as treatment for 
      hyperglycemia in T2DM were provided. In addition, evidence from large clinical 
      studies assessing cardiovascular outcomes following the use of sodium-glucose 
      cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists in 
      patients with T2DM were incorporated into the recommendations.
CI  - Copyright (c) 2019 Korean Diabetes Association.
FAU - Kim, Mee Kyoung
AU  - Kim MK
AUID- ORCID: 0000-0003-3205-9114
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, 
      Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of 
      Korea, Seoul, Korea.
FAU - Ko, Seung Hyun
AU  - Ko SH
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, St. 
      Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, 
      Korea.
FAU - Kim, Bo Yeon
AU  - Kim BY
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, 
      Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of 
      Medicine, Bucheon, Korea.
FAU - Kang, Eun Seok
AU  - Kang ES
AD  - Department of Internal Medicine, Yonsei University College of Medicine, Seoul, 
      Korea.
FAU - Noh, Junghyun
AU  - Noh J
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, Inje 
      University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, 
      Korea.
FAU - Kim, Soo Kyung
AU  - Kim SK
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, CHA 
      Bundang Medical Center, CHA University, Seongnam, Korea.
FAU - Park, Seok O
AU  - Park SO
AD  - Gwangmyeong Sungae Hospital, Gwangmyeong, Korea.
FAU - Hur, Kyu Yeon
AU  - Hur KY
AD  - Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical 
      Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
FAU - Chon, Suk
AU  - Chon S
AD  - Department of Endocrinology and Metabolism, Kyung Hee University School of 
      Medicine, Seoul, Korea.
FAU - Moon, Min Kyong
AU  - Moon MK
AD  - Department of Internal Medicine, Seoul Metropolitan Government Seoul National 
      University Boramae Medical Center, Seoul National University College of Medicine, 
      Seoul, Korea.
FAU - Kim, Nan Hee
AU  - Kim NH
AD  - Department of Internal Medicine, Korea University College of Medicine, Ansan, 
      Korea.
FAU - Kim, Sang Yong
AU  - Kim SY
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, Chosun 
      University College of Medicine, Gwangju, Korea.
FAU - Rhee, Sang Youl
AU  - Rhee SY
AD  - Department of Endocrinology and Metabolism, Kyung Hee University School of 
      Medicine, Seoul, Korea.
FAU - Lee, Kang Woo
AU  - Lee KW
AD  - Sejong St. Mary's Diabetes and Endocrine Clinic, Sejong, Korea.
FAU - Kim, Jae Hyeon
AU  - Kim JH
AD  - Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical 
      Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
FAU - Rhee, Eun Jung
AU  - Rhee EJ
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, 
      Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, 
      Korea.
FAU - Chun, SungWan
AU  - Chun S
AD  - Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, 
      Soonchunhyang University College of Medicine, Cheonan, Korea.
FAU - Yu, Sung Hoon
AU  - Yu SH
AD  - Department of Endocrinology and Metabolism, Hanyang University Guri Hospital, 
      Hanyang University College of Medicine, Guri, Korea.
FAU - Kim, Dae Jung
AU  - Kim DJ
AD  - Department of Endocrinology and Metabolism, Ajou University School of Medicine, 
      Suwon, Korea.
FAU - Kwon, Hyuk Sang
AU  - Kwon HS
AUID- ORCID: 0000-0003-4026-4572
AD  - Division of Endocrinology and Metabolism, Department of Internal Medicine, 
      Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of 
      Korea, Seoul, Korea. drkwon@catholic.ac.kr.
FAU - Park, Kyong Soo
AU  - Park KS
AD  - Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School 
      of Convergence Science and Technology, Seoul National University, Seoul, Korea.
AD  - Department of Internal Medicine, Seoul National University College of Medicine, 
      Seoul, Korea.
CN  - Committee of Clinical Practice Guidelines, Korean Diabetes Association
LA  - eng
PT  - Journal Article
PT  - Practice Guideline
PT  - Review
PL  - Korea (South)
TA  - Diabetes Metab J
JT  - Diabetes & metabolism journal
JID - 101556588
RN  - 0 (Antihypertensive Agents)
RN  - 0 (GLP1R protein, human)
RN  - 0 (Glucagon-Like Peptide-1 Receptor)
RN  - 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors)
RN  - 0 (Hypoglycemic Agents)
RN  - 0 (Sodium-Glucose Transporter 2 Inhibitors)
MH  - Adult
MH  - Antihypertensive Agents/*therapeutic use
MH  - Diabetes Mellitus, Type 2/diagnosis/*drug therapy/*epidemiology
MH  - Diabetic Nephropathies/drug therapy
MH  - Glucagon-Like Peptide-1 Receptor/*agonists
MH  - Humans
MH  - Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use
MH  - Hypoglycemic Agents/*therapeutic use
MH  - Obesity/drug therapy
MH  - Prevalence
MH  - Republic of Korea/epidemiology
MH  - Sodium-Glucose Transporter 2 Inhibitors/*therapeutic use
MH  - Weight Loss
PMC - PMC6712226
OTO - NOTNLM
OT  - Diabetes mellitus, type 2
OT  - Diagnosis
OT  - Practice guideline
OT  - Therapeutics
COIS- No potential conflict of interest relevant to this article was reported.
EDAT- 2019/08/24 06:00
MHDA- 2019/08/24 06:01
PMCR- 2019/08/01
CRDT- 2019/08/24 06:00
PHST- 2019/07/16 00:00 [received]
PHST- 2019/07/22 00:00 [accepted]
PHST- 2019/08/24 06:00 [entrez]
PHST- 2019/08/24 06:00 [pubmed]
PHST- 2019/08/24 06:01 [medline]
PHST- 2019/08/01 00:00 [pmc-release]
AID - 43.398 [pii]
AID - 10.4093/dmj.2019.0137 [doi]
PST - ppublish
SO  - Diabetes Metab J. 2019 Aug;43(4):398-406. doi: 10.4093/dmj.2019.0137.